2-47414420-TAAAAAAAAAAAAAAAAAAA-TAAAAAAAAAAAAAAAAAA

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The ENST00000233146.7(MSH2):​c.942+3delA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). The gene MSH2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.52 ( 7247 hom., cov: 0)
Exomes 𝑓: 0.19 ( 2857 hom. )
Failed GnomAD Quality Control

Consequence

MSH2
ENST00000233146.7 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:12

Conservation

PhyloP100: 2.32

Publications

4 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 2-47414420-TA-T is Benign according to our data. Variant chr2-47414420-TA-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 374958.
BS2
High Homozygotes in GnomAdExome4 at 2857 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000233146.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.942+29delA
intron
N/ANP_000242.1P43246-1
MSH2
NM_001406674.1
c.942+29delA
intron
N/ANP_001393603.1
MSH2
NM_001406631.1
c.942+29delA
intron
N/ANP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.942+3delA
splice_region intron
N/AENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.942+3delA
splice_region intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.993+3delA
splice_region intron
N/AENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.523
AC:
32386
AN:
61918
Hom.:
7242
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.378
Gnomad AMI
AF:
0.482
Gnomad AMR
AF:
0.622
Gnomad ASJ
AF:
0.604
Gnomad EAS
AF:
0.604
Gnomad SAS
AF:
0.542
Gnomad FIN
AF:
0.593
Gnomad MID
AF:
0.570
Gnomad NFE
AF:
0.585
Gnomad OTH
AF:
0.567
GnomAD2 exomes
AF:
0.0792
AC:
4150
AN:
52420
AF XY:
0.0737
show subpopulations
Gnomad AFR exome
AF:
0.0689
Gnomad AMR exome
AF:
0.126
Gnomad ASJ exome
AF:
0.0620
Gnomad EAS exome
AF:
0.105
Gnomad FIN exome
AF:
0.0125
Gnomad NFE exome
AF:
0.0627
Gnomad OTH exome
AF:
0.113
GnomAD4 exome
AF:
0.186
AC:
174831
AN:
937556
Hom.:
2857
Cov.:
0
AF XY:
0.183
AC XY:
84884
AN XY:
463688
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.121
AC:
2489
AN:
20568
American (AMR)
AF:
0.107
AC:
1776
AN:
16622
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
1865
AN:
13994
East Asian (EAS)
AF:
0.130
AC:
2853
AN:
21890
South Asian (SAS)
AF:
0.134
AC:
6972
AN:
51882
European-Finnish (FIN)
AF:
0.115
AC:
2288
AN:
19934
Middle Eastern (MID)
AF:
0.172
AC:
408
AN:
2376
European-Non Finnish (NFE)
AF:
0.199
AC:
149819
AN:
753694
Other (OTH)
AF:
0.174
AC:
6361
AN:
36596
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.362
Heterozygous variant carriers
0
8754
17509
26263
35018
43772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6704
13408
20112
26816
33520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.523
AC:
32391
AN:
61922
Hom.:
7247
Cov.:
0
AF XY:
0.519
AC XY:
14222
AN XY:
27428
show subpopulations
African (AFR)
AF:
0.378
AC:
7206
AN:
19056
American (AMR)
AF:
0.622
AC:
2565
AN:
4126
Ashkenazi Jewish (ASJ)
AF:
0.604
AC:
1069
AN:
1770
East Asian (EAS)
AF:
0.605
AC:
991
AN:
1638
South Asian (SAS)
AF:
0.543
AC:
601
AN:
1106
European-Finnish (FIN)
AF:
0.593
AC:
375
AN:
632
Middle Eastern (MID)
AF:
0.571
AC:
56
AN:
98
European-Non Finnish (NFE)
AF:
0.585
AC:
18846
AN:
32220
Other (OTH)
AF:
0.569
AC:
437
AN:
768
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
540
1079
1619
2158
2698
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
1
1
Lynch syndrome 1 (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
1
-
Mismatch repair cancer syndrome 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.3
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11309117; hg19: chr2-47641559; COSMIC: COSV99253990; COSMIC: COSV99253990; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.